Skip to Main Content

++

Rare form of systemic occlusive arteriopathy of small and medium-size arteries with a typical two-stage evolution. Disease affects vessels of the dermis with an aspect of erythematous, dome-shaped papules that develop a central area of necrosis and leave a porcelain-like scar. Gastrointestinal tract and CNS can be affected. Can be fatal.

++

Malignant Atrophic Papulosis; Papulosis, Malignant Atrophic; Degos Disease; Degos-Kohlmeier Disease; Kohlmeier-Degos Disease.

++

Disease was first described in 1941 by W. Kohlmeier, a German radiologist, and first individualized in 1942 by Robert Degos, a French dermatologist.

++

Autosomal dominant inheritance is observed in familial cases.

++

Unknown. Familial cases have been described. Immunologic, infectious, or thrombotic factors have been evocated.

++

Clinically evocated onset usually in young adults between 20 and 40 years old, probably with male predominance. Characteristic skin lesions (pink, asymptomatic, diffuse papules with a telangiectatic border followed by umbilication and a porcelain-white center) appear. Histologic appearance is typically characterized by a wedge-shaped area of necrosis from the epidermis through the dermis.

++

Skin lesions can be followed by systemic manifestations, sometimes a few years later. Features can involve the eyes (avascular patches), CNS (20% cerebrovascular or medullar accident), and GI system (40-60%, particularly small bowel with abdominal pain, bleeding, and diarrhea; intestinal perforations and peritonitis are the leading causes of death). Pleural and pericardial effusion can be observed.

++

Obtain full history. Evaluate neurologic lesions (clinical, CT/MRI). Pleural and pericardial effusion must be searched and treated before anesthesia if necessary (clinical, ECG, chest radiographs, echography). Full blood count is necessary.

++

Eye protection is needed. Spinal and perimedullar blockades probably should be avoided because of the frequency of medullar accidents. Should obtain a bleeding time and coagulation profile.

++

Aspirin is often used to treat patients. Heparin substitution should be considered.

Degos R, Delort J, Triscot R: Dermatite papulo squameuse atrophiante. Bull Soc Franc Derm Syph 49:148, 1942.
Ojeda Cuchillero RM, Sanchez Regana M, Umbert Millet P: Benign cutaneous Degos' disease. Clin Exp Dermatol 28:145, 2003.
Torrelo A, Sevilla J, Mediero IG, et al: Malignant atrophic papulosis in an infant. Br J Dermatol 146:916, 2002.  [PubMed: 12000397]

Want remote access to your institution's subscription?

Sign in to your MyAccess profile while you are actively authenticated on this site via your institution (you will be able to verify this by looking at the top right corner of the screen - if you see your institution's name, you are authenticated). Once logged in to your MyAccess profile, you will be able to access your institution's subscription for 90 days from any location. You must be logged in while authenticated at least once every 90 days to maintain this remote access.

Ok

About MyAccess

If your institution subscribes to this resource, and you don't have a MyAccess profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.

Subscription Options

AccessAnesthesiology Full Site: One-Year Subscription

Connect to the full suite of AccessAnesthesiology content and resources including procedural videos, interactive self-assessment, real-life cases, 20+ textbooks, and more

$995 USD
Buy Now

Pay Per View: Timed Access to all of AccessAnesthesiology

24 Hour Subscription $34.95

Buy Now

48 Hour Subscription $54.95

Buy Now

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.